Evidence map›Paper›PMID 35048535›Full record

ArticleClinical and translational science2022

Peppermint oil effects on the gut microbiome in children with functional abdominal pain.

Santosh Thapa, Ruth Ann Luna, Bruno P Chumpitazi, Numan Oezguen, Susan M Abdel-Rahman, Uttam Garg, Salma Musaad, James Versalovic, Gregory L Kearns, Robert J Shulman

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical and translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03295747 (Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03295747 phase1completednot on this map

Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain

TypeinterventionalSponsorRobert Shulman, M.D.Ran2017 to 2019Enrolled30ConditionsAbdominal PainArmsPeppermint oil
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Investigating the Health Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Santosh ThapaDepartment of Pathology, Texas Children's Microbiome Center, Texas Children's Hospital, Houston, Texas, USA.
Ruth Ann LunaDepartment of Pathology, Texas Children's Microbiome Center, Texas Children's Hospital, Houston, Texas, USA.
Bruno P ChumpitaziDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Numan OezguenDepartment of Pathology, Texas Children's Microbiome Center, Texas Children's Hospital, Houston, Texas, USA.
Susan M Abdel-RahmanUniversity of Missouri School of Medicine, Kansas City, Missouri, USA.
Uttam GargDepartment of Pathology and Laboratory Medicine, Children's Mercy Hospital, University of Missouri School of Medicine, Kansas City, Missouri, USA.
Salma MusaadDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
James VersalovicDepartment of Pathology, Texas Children's Microbiome Center, Texas Children's Hospital, Houston, Texas, USA.
Gregory L KearnsTexas Christian University and University of North Texas Health Science Center School of Medicine, Fort Worth, Texas, USA.
Robert J ShulmanDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Baylor College of Medicine · USTexas Children's Hospital · USChildren's Mercy Hospital · USUniversity of Missouri–Kansas City · USUniversity of North Texas Health Science Center · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children with Functional Abdominal PainR21AT009101 · NCCIH · BAYLOR COLLEGE OF MEDICINE · PI SHULMAN, ROBERT J · 2016 to 2017
$436k
NCCIH NIH HHS R21 AT009101NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

Peppermint oil (PMO) is effective in the treatment of functional abdominal pain disorders, but its mechanism of action is unclear. Evidence suggests PMO has microbicidal activity. We investigated the effect of three different doses of PMO on gut microbiome composition. Thirty children (7-12 years of age) with functional abdominal pain provided a baseline stool sample prior to randomization to 180, 360, or 540 mg of enteric coated PMO (10 participants per dose). They took their respective dose of PMO (180 mg once, 180 mg twice, or 180 mg thrice daily) for 1 week, after which the stool collection was repeated. Baseline and post-PMO stools were analyzed for microbiome composition. There was no difference in alpha diversity of the gut microbiome between the baseline and post-PMO treatment. Principal coordinate analysis revealed no significant difference in overall bacterial composition between baseline and post-PMO samples, as well as between the PMO dose groups. However, the very low abundant Collinsella genus and three operational taxonomic units (one belonging to Collinsella) were significantly different in samples before and after PMO treatment. The Firmicutes/Bacteroidetes ratio was lower in children who received 540 mg of PMO compared to the 180 mg and 360 mg dose groups (p = 0.04). Network analysis revealed separation between pre- and post-PMO fecal samples with the genus Collinsella driving the post-PMO clusters. PMO administration appeared to impact only low abundance bacteria. The 540 mg PMO dose differentially impacted the Firmicutes/Bacteroidetes ratio. A higher dose and/or longer duration of treatment might yield different results.

Indexed as

Gastrointestinal MicrobiomeAbdominal PainBacteroidetesChildFecesHumansMentha piperitaPlant Oilspeppermint oilPlant Oils

Identifiers

PMID35048535
PMCPMC9010253
OpenAlexW4206318239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.